Alexis Genaix
About Alexis Genaix
Alexis Genaix is the Responsable Pharmacovigilance Cardiovasculaire at Bristol-Myers Squibb in New York, specializing in cardiovascular pharmacovigilance with over a decade of experience in the field.
Title
Alexis Genaix is currently the Responsable Pharmacovigilance Cardiovasculaire at Bristol-Myers Squibb, located in New York, New York, United States.
Current Company
Alexis Genaix is employed at Bristol-Myers Squibb, where he specializes in cardiovascular pharmacovigilance. In his role, he focuses on monitoring and evaluating the safety of cardiovascular drugs, ensuring compliance with industry regulations and standards.
Previous Experience at Axpharma
Prior to his current position, Alexis Genaix worked at Axpharma in Paris, Île-de-France, France. He initially joined Axpharma as a junior pharmacovigilant for a 7-month period in 2012. He later served as a Pharmacien Pharmacovigilant - Drug Safety Officer from 2012 to 2016. During his tenure, he gained extensive experience in drug safety and pharmacovigilance practices.
Roles in Immunology and Pharmacovigilance
Alexis Genaix has also held the position of Responsable Pharmacovigilance Senior Immuno. In this senior role, he was responsible for overseeing pharmacovigilance activities related to immunological drugs, further broadening his expertise in the field.
Education and Expertise
Alexis Genaix studied at Université Paris Descartes, where he completed a Master's program over six years, from 2006 to 2012. His comprehensive education has provided him with a solid foundation in pharmacovigilance, allowing him to build a career that spans over a decade in the field.